Status:
COMPLETED
Adalimumab in Adult Japanese Subjects With Psoriasis
Lead Sponsor:
Abbott
Collaborating Sponsors:
Abbott Japan Co.,Ltd
Eisai Co., Ltd.
Conditions:
Psoriasis
Eligibility:
All Genders
20+ years
Phase:
PHASE2
PHASE3
Brief Summary
To evaluate efficacy, safety, and pharmacokinetics of adalimumab in Japanese participants with psoriasis
Detailed Description
This was a continuation trial of adalimumab in participants with moderate to severe chronic plaque psoriasis who had completed Study M04-688 (NCT00338754), a 24-week, double-blind, placebo-controlled ...
Eligibility Criteria
Inclusion
- \- Participants who completed Study M04-688 (NCT00338754)
Exclusion
- \- Participant is considered by the investigator, for any reason, to be an unsuitable candidate for the study
Key Trial Info
Start Date :
April 1 2006
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
April 1 2010
Estimated Enrollment :
147 Patients enrolled
Trial Details
Trial ID
NCT00647400
Start Date
April 1 2006
End Date
April 1 2010
Last Update
April 8 2011
Active Locations (64)
Enter a location and click search to find clinical trials sorted by distance.
1
Site Ref # / Investigator 5491
Bunkyō City, Japan
2
Site Ref # / Investigator 5429
Chiyoda-ku, Japan
3
Site Ref # / Investigator 5464
Fukuoka, Japan
4
Site Ref # / Investigator 5477
Fukuoka, Japan